288 related articles for article (PubMed ID: 26791964)
21. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.
Mittal R; Araujo I; Czanner G; Coupland SE
Acta Ophthalmol; 2016 Aug; 94(5):e325-30. PubMed ID: 26843360
[TBL] [Abstract][Full Text] [Related]
22. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
[TBL] [Abstract][Full Text] [Related]
23. Periocular sebaceous gland carcinoma: do androgen receptor (NR3C4) and nuclear survivin (BIRC5) have a prognostic significance?
Mulay K; Shah SJ; Aggarwal E; White VA; Honavar SG
Acta Ophthalmol; 2014 Dec; 92(8):e681-7. PubMed ID: 24930483
[TBL] [Abstract][Full Text] [Related]
24. Expression of Shh and Wnt signaling pathway proteins in eyelid sebaceous gland carcinoma: clinicopathologic study.
Kim N; Kim JE; Choung HK; Lee MJ; Khwarg SI
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):370-7. PubMed ID: 23249701
[TBL] [Abstract][Full Text] [Related]
25. 14-year case series of eyelid sebaceous gland carcinoma in Chinese patients and review of management.
Lam SC; Li EYM; Yuen HKL
Br J Ophthalmol; 2018 Dec; 102(12):1723-1727. PubMed ID: 29459429
[TBL] [Abstract][Full Text] [Related]
26. miRNA-200c and miRNA-141 as potential prognostic biomarkers and regulators of epithelial-mesenchymal transition in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Chosdol K; Sharma A; Pushker N; Kashyap S; Bakhshi S; Bajaj MS
Br J Ophthalmol; 2017 Apr; 101(4):536-542. PubMed ID: 28119291
[TBL] [Abstract][Full Text] [Related]
27. Common presentations of sebaceous gland carcinoma of the eyelid.
Wagoner MD; Beyer CK; Gonder JR; Albert DM
Ann Ophthalmol; 1982 Feb; 14(2):159-63. PubMed ID: 7092023
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a nomogram to predict the recurrence of eyelid sebaceous gland carcinoma.
Nie Z; Geng J; Xu X; Zhang R; Li D
Cancer Med; 2023 Jul; 12(14):14912-14921. PubMed ID: 37387455
[TBL] [Abstract][Full Text] [Related]
29. Retinoid receptor subtypes in sebaceous cell carcinoma of the eyelid.
Chakravarti N; Saadati HG; El-Naggar AK; Lotan R; Diba RE; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2005 Jul; 21(4):292-7. PubMed ID: 16052143
[TBL] [Abstract][Full Text] [Related]
30. Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin.
Jakobiec FA; Mendoza PR
Am J Ophthalmol; 2014 Jan; 157(1):186-208.e2. PubMed ID: 24112633
[TBL] [Abstract][Full Text] [Related]
31. Recurrent sebaceous gland carcinoma of eyelid previously diagnosed as basal cell carcinoma: case report.
Kan LW; Leu YS; Tzen CY; Wu CH
Am J Otolaryngol; 2011; 32(6):620-3. PubMed ID: 21168242
[TBL] [Abstract][Full Text] [Related]
32. Reverse masquerade: primary eyelid amyloidosis mimicking sebaceous gland carcinoma.
Shahid Alam M
Orbit; 2022 Jun; 41(3):392. PubMed ID: 33779482
[No Abstract] [Full Text] [Related]
33. Correlation of the expression of telomerase RNA with risk factors for recurrence of sebaceous gland carcinoma.
Li B; Li N; Cheng G; Sun X; Xu X; Shi J; Li L; Chen C
Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):480-4. PubMed ID: 16133023
[TBL] [Abstract][Full Text] [Related]
34. Impact of clinicopathologic factors on survival in patients with sebaceous carcinoma of the eyelid - a population-based analysis.
Lee IJ; Koh JY
Orbit; 2019 Aug; 38(4):261-268. PubMed ID: 30373440
[No Abstract] [Full Text] [Related]
35. Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients.
Sa HS; Rubin ML; Xu S; Ning J; Tetzlaff M; Sagiv O; Kandl TJ; Esmaeli B
Br J Ophthalmol; 2019 Jul; 103(7):980-984. PubMed ID: 30131380
[TBL] [Abstract][Full Text] [Related]
36. Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid.
Kiyosaki K; Nakada C; Hijiya N; Tsukamoto Y; Matsuura K; Nakatsuka K; Daa T; Yokoyama S; Imaizumi M; Moriyama M
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):7-11. PubMed ID: 19628749
[TBL] [Abstract][Full Text] [Related]
37. Sebaceous gland carcinoma of tarsus can be misdiagnosed as intratarsal keratinous cyst.
Ha A; Kim N
Can J Ophthalmol; 2016 Jun; 51(3):e99-e101. PubMed ID: 27316293
[No Abstract] [Full Text] [Related]
38. Prognosis of eyelid sebaceous gland carcinoma based on the tumor (T) category of the American Joint Committee on Cancer (AJCC) classification.
Kaliki S; Gupta A; Ali MH; Ayyar A; Naik MN
Int Ophthalmol; 2016 Oct; 36(5):681-90. PubMed ID: 26830096
[TBL] [Abstract][Full Text] [Related]
39. E-cadherin and β-catenin expression in sebaceous eyelid adenocarcinomas.
Li L; Zhang Z; Li B; Gao F; Li L; Jonas JB
Graefes Arch Clin Exp Ophthalmol; 2011 Dec; 249(12):1867-73. PubMed ID: 21739269
[TBL] [Abstract][Full Text] [Related]
40. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas.
Jakobiec FA; Werdich X
Am J Ophthalmol; 2014 Mar; 157(3):687-96.e1-2. PubMed ID: 24333189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
